公司資料
Smith and Nephew 股價、新聞與催化劑
- 股票代碼:
- SNN
- 交易所:
- NYSE
- 產業:
- MedTech
- 所在地:
- United Kingdom and listed in the U
股票表現
29.04 USD (-0.92%)
收盤價
最後更新: 2026年8月20日
12.5B USD
市值
股價為何變動
As of Aug 20, 2026, SNN closed down 0.92% at $29.04. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Smith & Nephew is a global medical technology company focused on orthopedics, sports medicine, and advanced wound management. Its business is driven by procedure-linked demand and product innovation across surgical and restorative care.
所在地與產業分類
Headquartered in the United Kingdom and listed in the U.S. as an ADR, Smith & Nephew has a broad international footprint. It sits in medtech rather than biotech.
商業模式特徵
The company earns revenue through implants, surgical systems, wound care, and related products used in hospitals and clinics. Investors watch procedure volumes, product launches, and margin trends across its core franchises.
生技產業定位
Smith & Nephew is outside biotech but important within healthcare technology because it benefits from surgical and wound-care demand. It tends to move on clinical adoption and hospital utilization rather than drug events.
未來催化劑
- Smith & Nephew’s watchpoints are robotics adoption, sports-medicine execution, and continued recovery in orthopedics. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。